Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,487 papers from all fields of science
Search
Sign In
Create Free Account
idoxifene
Known as:
Pyr-I-Tam
, 4-iodopyrrolidinotamoxifen
, 1-[2-[4-[(1E)-1-(4-Iodophenyl)-2-phenyl-1-butenyl]phenoxy]ethyl]pyrrolidine
Expand
A drug that blocks the effects of estrogen.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Estrogen Antagonists
Tamoxifen
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene.
S. Rehm
,
H. Solleveld
,
S. Portelli
,
P. Wier
Birth defects research. Part B. Developmental and…
2007
Corpus ID: 44730380
BACKGROUND Idoxifene is a selective estrogen receptor modulator similar to tamoxifen but is no longer in pharmaceutical…
Expand
2002
2002
Comparison of the effects of EM‐652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW‐5638 and raloxifene on the growth of human ZR‐75‐1 breast tumors in nude mice
M. Gutman
,
S. Couillard
,
J. Roy
,
F. Labrie
,
B. Candas
,
C. Labrie
International Journal of Cancer
2002
Corpus ID: 26226620
EM‐652 exerts pure antiestrogenic activity in the mammary gland and endometrium, while tamoxifen, the antiestrogen most widely…
Expand
Review
2001
Review
2001
Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function.
D. Herrington
,
K. Klein
Women's health issues
2001
Corpus ID: 3129758
Highly Cited
2000
Highly Cited
2000
Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer.
M. Dowsett
,
J. Dixon
,
K. Horgan
,
J. Salter
,
M. Hills
,
Eileen Harvey
Clinical Cancer Research
2000
Corpus ID: 13461905
Idoxifene is a novel selective estrogen receptor modulator. It has reduced agonist activity on breast and uterine cells compared…
Expand
2000
2000
Selective Estrogen Receptor Modulator Idoxifene Inhibits Smooth Muscle Cell Proliferation, Enhances Reendothelialization, and Inhibits Neointimal Formation In Vivo After Vascular Injury
T. Yue
,
L. Vickery-Clark
,
+9 authors
E. Ohlstein
Circulation
2000
Corpus ID: 24844555
Background—Idoxifene (ID) is a tissue-selective estrogen receptor modulator (SERM). The pharmacological profile of ID in animal…
Expand
Highly Cited
2000
Highly Cited
2000
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
E. S. Lee
,
J. Schafer
,
+4 authors
V. Jordan
Clinical Cancer Research
2000
Corpus ID: 7140564
The triphenylethylene antiestrogens, idoxifene (Idox) and toremifene (Tor), are structurally related analogues of tamoxifen (Tam…
Expand
1999
1999
Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives, both chemically and in human and rat liver cells.
M. Osborne
,
A. Hewer
,
+4 authors
D. Phillips
Carcinogenesis
1999
Corpus ID: 39114930
The drug tamoxifen shows evidence of genotoxicity, and induces liver tumours in rats. Covalent DNA adducts have been detected in…
Expand
1998
1998
Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expression.
E. Nuwaysir
,
Y. Dragan
,
+4 authors
H. Pitot
Biochemical Pharmacology
1998
Corpus ID: 36678732
1998
1998
Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast-cancer cell lines
Lu Jin
,
N. Legros
,
G. Leclercq
,
I. Hardcastle
,
M. Jarman
Cancer Chemotherapy and Pharmacology
1998
Corpus ID: 21329443
Abstract Linkage of specific residues onto steroidal estrogens through a long aliphatic side chain leads to “pure antiestrogens…
Expand
Highly Cited
1994
Highly Cited
1994
Inhibition of volume-activated I- and taurine efflux from HeLa cells by P-glycoprotein blockers correlates with calmodulin inhibition.
J. Kirk
,
K. Kirk
Journal of Biological Chemistry
1994
Corpus ID: 21319994
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE